Founded in May 1978, Farmindustria is an Association set up by the pharmaceutical companies operating in Italy. It is a member of Confindustria, the principal national confederation of manufacturing and service companies, the European Federation (EFPIA) and the World Federation (IFPMA). Farmindustria’s members number around 200 companies and include both national and foreign-owned enterprises.
With over 120 factories throughout the country and 67,000 highly qualified employees, of whom about half (43%) are women and with increasingly younger employees (the under-35s represent 42% of all new recruits), pharmaceutical companies in Italy play a strategic role in the country, and with an overall production value of € 34.3 billion, they are leaders in Europe together with France and Germany.
Italy, thanks to its 6,750 researchers and investments in excess of € 3 billion per year (1.42 in production and 1.62 in Research and Development), is a leading protagonist in pharmaceutical research. The sector's specializations in biotech medicines, advanced therapies, orphan medicines, plasma-derived products, vaccines and clinical studies are ample confirmation of its prowess. However, such pre-eminence is always the result of partnerships in the territory as well as cooperation with public and private centres of excellence, universities, science parks, start-ups and non-profit organizations.
The pharmaceutical industry is a mainstay of the national economy: in the five-year period 2015-2020, its exports exceeded, on average, 80% of production, while employment in the sector recorded the highest growth in Italy. Moreover, the industry has long-term commitment to a more sustainable economy and a more inclusive society that pays ever greater attention to the health, well-being and training of people, in line with the United Nations’ 2030 goals.
In this respect, Farmindustria has launched numerous initiatives bearing the hallmark of social responsibility and many of these go back several years. As a concrete and constructive contribution towards tackling the phenomenon of Neet, the Association has organised two Active Policy projects for young people: the Alternanza Scuola Lavoro, a dual-training system program designed to give students career guidance, and the ITS (Higher Technical Institutes) to train young people for jobs requiring specialized sector skills.
Our industry recognizes the value of working people and provides them with one of the most advanced and effective corporate welfare while at the same time addressing different needs in terms of diversity & inclusion, work-life balance, health welfare - especially as regards caregivers - and welfare for the family in order to promote the birth rate.
To ensure the utmost fairness of business practice, Farmindustria’s associate companies have implemented a Code of Conduct - to date, one of the most rigorous in Europe - which regulates relations between companies and companies’ relations with the scientific and healthcare world.
In this period of pandemic emergency, pharmaceutical companies have been at the forefront in the fight against COVID-19 by ensuring continuity and access to care and engaging in R&D for therapies, vaccines and diagnostic tests. In Italy, companies have contributed towards the management of the crisis by donating medicines, goods and services, as well as taking initiatives to support patients, doctors and all the supply-chain staff, by ensuring operational continuity in factories in complete safety.
The Association endeavours to create a stable regulatory environment and a pharmaceutical policy that recognizes that this sector plays a vital role in stimulating and growing the country’s life sciences.
Farmindustria is also engaged in enhancing the public’s awareness of pharmaceutical and research companies. Hence, it promotes “roadshows” held on the premises of associated companies where innovation and the production of value can be seen to take place and to reflect on the policies necessary to stimulate development.
Furthermore, the Association presented “The clock of life”, to highlight how medicines are contributing towards the increase in life expectancy.
|Avenue de la Joyeuse Entrée - B - 1040 Bruxelles
||+ 32 2 2861255